Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Form 8.5 (EPT/RI) - Abrdn European Logistics Income Plc
-
Form 8.5 (EPT/RI) - Kin and Carta Plc
-
GTreasury Customer Subway Wins Treasury Management International’s Gold Award for Best TMS Implementation
-
UP Fintech Holding Limited to Report Fourth Quarter and Full Year 2023 Financial Results on March 20, 2024
-
Recursion Announces Plans to Open New Office in London
-
Offentliggørelse af investorinformationer, Kapitalforeningen Wealth Invest
-
Offentliggørelse af prospekt, Investeringsforeningen SEBinvest
-
Offentliggørelse af prospekter, Investeringsforeningen Wealth Invest
-
17/2024・Trifork Holding AG – Weekly report on share buyback
-
Aktia clarifies its strategic priorities and targets – employee experience added as part of the strategy
-
CallTower Strengthens Channel Partnership Operations Through Team Expansion
-
Regenx Approaching 50% Production Objectives
-
Shell Plc Fourth Quarter 2023 Euro and Gbp Equivalent Dividend Payments
-
Mkango Subsidiary, Maginito, and CoTec Appoint Lead Engineers BBA and Pegasus to Complete the Feasibility Study for HyProMag USA
-
Fingerprints supports Thales Biometric Payment Card first launch in Türkiye with Garanti BBVA
-
Holding(s) in Company
-
Subsea7 share repurchases
-
Transaction in Own Shares
-
Shell Plc Fourth Quarter 2023 Euro and Gbp Equivalent Dividend Payments
-
SAFE - Bond financing agreement in a minimum amount of €850,000 to support the Group’s turnaround strategy
-
ASML publishes agenda Annual General Meeting 2024
-
Press release - SPIE signs an agreement for the acquisition of ICG Group in Germany
-
Lleida.net signs a contract with Transolver Service SA.
-
Boehringer Ingelheim and Sosei Heptares join forces to develop first-in-class treatments targeting all symptoms of schizophrenia
-
ONWARD® Medical Accepted to New US FDA TAP Program for Development of its ARC-BCI™ System
-
ONWARD® Medical Accepted to New US FDA TAP Program for Development of its ARC-BCI™ System
-
BGHL (GBP): NAV(s)
-
BGHL (EUR): NAV(s)
-
Continued strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea
-
PolTREG receives CGMP certification to produce cell therapies at its state-of-the-art manufacturing site in Poland
-
Start of Day Message
-
Press Release: New Phase 2b results for amlitelimab support potential for best-in-class maintenance of response in atopic dermatitis
-
Strong FY 2023 results, Planisware consistently delivering sustainable profitable growth
-
The net asset value of EfTEN Real Estate Fund AS shares as of 29.02.2024
-
PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market
-
PolTREG receives CGMP certification to produce cell therapies at its state-of-the-art manufacturing site in Poland
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against iRhythm, Hut 8, and Amplitude and Encourages Investors to Contact the Firm
-
VCI Global Limited Establishes Support For Wisdom Accelerator Youth (WAY) Alongside The World Economic Forum
-
United States Food & Drug Administration (FDA) Supports Accelerated Approval Pathway for Rexlemestrocel-L in End-Stage Heart Failure Patients with a Left Ventricular Assist Device (LVAD)
-
United States Food & Drug Administration (FDA) Supports Accelerated Approval Pathway for Rexlemestrocel-L in End-Stage Heart Failure Patients with a Left Ventricular Assist Device (LVAD)
-
Thousands of Americans Settle Their Debts with the Assistance of Creditor Law Group
-
Euro Manganese Advances to Next Stage of Debt Funding Process with the European Investment Bank
-
Arcutis Presents Late-Breaking Data From INTEGUMENT-PED Phase 3 Trial of Roflumilast Cream 0.05% in Atopic Dermatitis in Children Ages 2 to 5 at the American Academy of Dermatology Annual Meeting
-
Ensurge Micropower ASA - Investor Presentation
-
HostAI Revolutionizes Cloud Infrastructure with DePIN Technology
-
ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Archer-Daniels-Midland Company Investors to Secure Counsel Before Important Deadline in Securities Class Action – ADM
-
MoonLake announces significant improvements with Nanobody® sonelokimab over 24 weeks in active psoriatic arthritis (PsA) and other important updates at its R&D Day
-
MoonLake announces significant improvements with Nanobody® sonelokimab over 24 weeks in active psoriatic arthritis (PsA) and other important updates at its R&D Day
-
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II Investors to Secure Counsel Before Important Deadline in Securities Class Action –
-
DefiQuant Capitalizes on Bitcoin's Market Dynamics with Advanced Automated Trading Solutions

